Search

everythinglearnresearchcommunity

for

Search:↓

Early shedding of the inner root sheath in noninflamed hair follicles is a relatively specific sign of Central Centrifugal Cicatricial Alopecia.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Black patients with a specific type of hair loss have a much higher chance of lacking enough vitamin D.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Using dermoscopy improves diagnosis of scalp and hair disorders in children.

Using a special skin cream with gabapentin helped reduce symptoms of a certain scalp condition but didn't change nerve fibers or skin chemicals.

DNA analysis can help tailor alopecia treatment.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

Researchers found a white halo around hair in most patients with a specific type of hair loss, which helps in early diagnosis and treatment.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Hair transplants can effectively treat hair loss from CCCA in African American women if there's no inflammation.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

CCCA is a common scarring hair loss in African descent women, possibly linked to genetics, hair care practices, and health issues like diabetes.

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.

Dermatoscopy can help diagnose CCCA without visible hair loss, offering a less invasive option than biopsy.

PRP therapy can temporarily grow hair in CCCA patients but isn't a permanent cure.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

Uterine leiomyomas don't significantly change gene expression in the scalp of people with Central Centrifugal Cicatricial Alopecia.

Certain health conditions and hair care habits affect the treatment results for a scalp condition called Central Centrifugal Cicatricial Alopecia.

CCCA may be caused by both hair traction and an immune response.

Blood cell counts could help predict and treat alopecia areata and telogen effluvium.

Low-dose metformin may help hair regrowth and reduce inflammation in CCCA.

Topical metformin 10% cream may help treat central centrifugal cicatricial alopecia.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Patients with central centrifugal cicatricial alopecia often have higher rates of metabolic, autoimmune, and atopic conditions, as well as anxiety and depression.